WA
REGN icon

WFG Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

WFG Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$29K Buy
60
+10
+20% +$4.38K 0.01% 855
2017
Q1 		$19K Sell
50
-10
-17% -$3.71K 0.01% 901
2016
Q4 		$22K Hold
60
– – 0.01% 911
2016
Q3 		$24K Hold
60
– – 0.01% 908
2016
Q2 		$21K Buy
+60
New +$23.1K 0.01% 907
2015
Q1 		– Sell
-10
Closed -$4K – 2013
2014
Q4 		$4K Hold
10
– – ﹤0.01% 1714
2014
Q3 		$4K Hold
10
– – ﹤0.01% 1730
2014
Q2 		$3K Buy
+10
New +$2.96K ﹤0.01% 1774

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

WFG Advisors's REGN Position: Q2 2017 in Review

WFG Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 20% in Q2 2017, buying an estimated $4.38K and bringing the position to 60 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #855.

WFG Advisors first reported a position in REGN in Q2 2014 and has held it in 8 quarters since. 603 funds tracked by Wall St. Rank hold REGN as of Q2 2017.

  • WFG Advisors held 60 shares of Regeneron Pharmaceuticals worth $29K as of Q2 2017.
  • WFG Advisors bought 10 Regeneron Pharmaceuticals shares in Q2 2017, an estimated $4.38K.
  • Regeneron Pharmaceuticals made up 0.01% of WFG Advisors's portfolio in Q2 2017, its #855 holding.
  • WFG Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 8 quarters since.
  • 603 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.